Review of cancer therapies for the perioperative physician Review


Authors: Dabo-Trubelja, A.; Gottumukkala, V.
Review Title: Review of cancer therapies for the perioperative physician
Abstract: Advances in cancer treatments over the past decades combining chemotherapy with novel technologies in immunotherapies, radiation therapies, and interventional radiology have prolonged life expectancy. Patients have more options for treatments of their primary or metastatic diseases. Increased procedural techniques amid an aging population with multiple comorbidities present risks and challenges in the perioperative period.Chemotherapy remains the mainstay of cancer treatment, can be given intraoperatively, and is combined with other treatment modalities. Immunotherapy is particular to cancer cells while being less toxic to healthy cells. Cancer vaccines stimulate the immune system to stop disease progression. Oncolytic viruses enhance the immune system's cytotoxic effect and show promise to halt metastatic disease progression if present in the perioperative period. Novel techniques in radiation therapy combined with traditional treatments show enhanced survival. This review focuses on current cancer treatments encountered in the perioperative period.
Keywords: chemotherapy; radiation; radiotherapy; immunotherapy; cancer vaccines; interventional radiology; surgery; antibodies; virus; outcomes; therapy; anesthesia; patient; disease; anesthesiology; perioperative physician
Journal Title: Perioperative Medicine
Volume: 12
ISSN: 2047-0525
Publisher: Bmc  
Date Published: 2023-06-13
Start Page: 25
Language: English
ACCESSION: WOS:001004305300001
DOI: 10.1186/s13741-023-00315-1
PROVIDER: wos
PMCID: PMC10262136
PUBMED: 37312150
Notes: The MSK Cancer Center Support Grant (P30 CA008748) is acknowledged in the PubMed record and PDF. Corresponding author is MSK author Anahita Dabo‑Trubelja -- Source: Wos
Altmetric
Citation Impact
BMJ Impact Analytics
MSK Authors